The Company is a freestanding, multi-specialty Medicare-certified ambulatory surgery center with two operating rooms and six pre/postoperative bays. Surgical services include plastic surgery (79% of 2023 revenue), orthopedic surgery (15%) and other surgeries (6%). Management is in active discussions to bring in new surgical groups as well add additional operating rooms and patient bays, which would make it the largest freestanding ASC in its market.

INVESTMENT APPEAL

• Diverse Service Offerings: The Company provides a range of services including plastic surgery, pain management, orthopedic surgery, general surgery, ENT surgery, and pacemaker insertion. This diversity allows the Company to attract a broad patient base and cater to various medical needs.

• Strategic Location and Market Presence: The Company benefits from being located in a densely populated area with significant demand for outpatient surgical services. Its proximity to major hospitals and healthcare facilities also strengthens its position in the local market.

• Established Client Base and Relationships: The Company has a stable client base, including long-standing relationships with top surgeons and medical professionals.

• Growth Potential: With plans to expand its facility and attract more surgeons, the Company is well-positioned to capture additional market share.